Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Reviewing BrainsWay (NASDAQ:BWAY) and Paradigm Medical Industries (OTCMKTS:PDMI)
BrainsWay (NASDAQ:BWAY – Get Free Report) and Paradigm Medical Industries (OTCMKTS:PDMI – Get Free Report) are both medical companies, but...
Reviewing Heartland Financial USA (NASDAQ:HTLF) & Orrstown Financial Services (NASDAQ:ORRF)
Orrstown Financial Services (NASDAQ:ORRF – Get Free Report) and Heartland Financial USA (NASDAQ:HTLF – Get Free Report) are both finance...
Contrasting Stein Mart (OTCMKTS:SMRTQ) & GAP (NYSE:GAP)
GAP (NYSE:GAP – Get Free Report) and Stein Mart (OTCMKTS:SMRTQ – Get Free Report) are both retail/wholesale companies, but which...
Brokerages Set Constellium SE (NYSE:CSTM) PT at $21.00
Shares of Constellium SE (NYSE:CSTM – Get Free Report) have been given an average rating of “Moderate Buy” by the...
Reviewing Pharma-Bio Serv (OTCMKTS:PBSV) & 1847 (OTCMKTS:EFSH)
Institutional & Insider Ownership 6.3% of 1847 shares are owned by institutional investors. 4.0% of 1847 shares are owned by...
Contrasting Bancorp (NASDAQ:TBBK) & Solera National Bancorp (OTCMKTS:SLRK)
Solera National Bancorp (OTCMKTS:SLRK – Get Free Report) and Bancorp (NASDAQ:TBBK – Get Free Report) are both finance companies, but...